Zhongnan Medical Journal Press

Home Results

A total of 6 result was found. Results that relate to LIU Meng

Mechanism research of PI3K/AKT pathway regulating PHF19 gene expression in prostate cancer

Published on New Medicine 2024,34(2):121-128.
13252 times 3773 times

MING Daojing GUO Mengmeng ZHANG Jinhui LIU Mengyang SHI Minghui LIU Shuyan YUAN Shuai ZENG Xiantao

PI3K/AKT TP63 PHF19 Prostate cancer
Details
Investigation on mental health status of primary healthcare staffs in midwest areas of Inner Mongolia

Published on Journal of Mathematical Medicine 2024,37(3):164-170.
12313 times 4029 times

LIU Can LI Yingjie LIU Meng TANG Siyuan HAN Ke CHENG Jingmin

Primary healthcare staffs Mental health Influencing factors Inner Mongolia Midwest areas
Details
The expression of ASXL3 in prostate cancer

Published on New Medicine 2024,34(3):282-290.
13206 times 3515 times

ZHANG Jinhui LIU Mengyang CUI Jinlong REN Yiming CAI Yi MING Daojing REN Xuequn YUAN Shuai

ASXL3 Prostate cancer Prognosis Immune infiltration Biomarkers
Details
Pharmaceutical care of acute liver injury caused by intravenous amiodarone in a patient with pulmonary embolism-induced heart failure

Published on Chinese Journal of Pharmacoepidemiology 2024,33(8):955-960.
11027 times 2783 times

HE Yang LIU Meng

Pulmonary embolism Heart failure Liver injury Amiodarone Pharmaceutical care
Details
Effect of regulating miR-29b-3p/FoxO3 axis by asiaticoside on alleviating liver injury in rats with non-alcoholic fatty liver disease

Published on New Medicine 2025,35(10):1165-1172.
7039 times 1568 times

TAN Jie LIU Meng TIAN Xia HAN Zheng ZHU Qingxi ZHAN Ting CHEN Mingtao CHEN Aifang HUANG Min

Asiaticoside Non-alcoholic fatty liver disease Liver injury MicroRNA-29b-3p/forkhead box O3
Details
Pharmaceutical practice of bevacizumab-induced refractory hypertension and proteinuria in a patient with advanced lung adenocarcinoma

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1335-1339.
8612 times 1665 times

YAN Jiaju YUAN Yongyong LIU Meng

Bevacizumab Lung adenocarcinoma Resistant hypertension Proteinuria Phamaceutical care
Details